Xufeng Peng

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 17, 2022
Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation.

Fangzhou Li, Xufeng Peng, Jiale Zhou

Pageof 1